Clinical Trials Directory

Trials / Completed

CompletedNCT04491214

Post ICU Follow up in Patients With Severe SARS-CoV-2 Infection (Covid-19)

Status
Completed
Phase
Study type
Observational
Enrollment
112 (actual)
Sponsor
University Hospital, Strasbourg, France · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Patients affected by new coronavirus infectious disease (COVID) were mostly hospitalized in ICU. This infection seems to cause widespread organ injury (i.e acute renal injury, neurological disorders, pulmonary embolism,…). It is therefore necessary to provide a framework for the follow up of patients. Moreover SARS-CoV-2 infection consequences remain unknow at this time. Study hypothesis is that COVID alters determining factors (physical or psychological) of quality of life after ICU hospitalisation. The aim of the study is to assess quality of life 3 months after ICU hospitalization. Secondary purposes of the study are 1) assessment of quality of life 6 months and the evolution between the third and the sixth months after ICU hospitalization 2) description patients care after 3 and 6 months ICU left and their clinical status 3) convening and providing a "platform" within several physicians (neurologist, biologist, pneumologist…) will be able to follow up patients and perform complementary investigations according to patients injuries.

Conditions

Interventions

TypeNameDescription
OTHERquality of live assessmentquality of live assessment 3 moth and 6 moth after ointensive care hospitalisation using SF36.

Timeline

Start date
2020-07-24
Primary completion
2021-01-21
Completion
2021-01-21
First posted
2020-07-29
Last updated
2021-02-12

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04491214. Inclusion in this directory is not an endorsement.